INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

71,085 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
BG
Brace Philip GDirector, CEO and President
SWKSSKYWORKS SOLUTIONS, INC.
Tax withholding
F$1.35M
16.7K sh
Nov 5, 2026Nov 6, 2026
Page 21 of 1778
← PrevNext →
traded Nov 5, 2026
+1d
SEC Form 4

Evidence

30
HJ
Hazlin JohnChief Growth Officer
CLCOLGATE PALMOLIVE CO
Option exercise
M$1.80M
23.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
KN
Klein NirDirector, Chief Executive Officer
SYNXSilynxcom Ltd.
Open-market purchase
BUY$9,900
9,940 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
MV
Magliulo VirginiaExecutive VP
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$264K
852 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

30
SS
Swartz Donald SDirector, CEO and President
REARare Earths Americas, Inc.
Tax withholding
F$1.51M
183.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Option exercise
M$7.87M
6,900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Option exercise
M$8.64M
72.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
RH
Reiss Rena HozoreEVP & General Counsel
MARMARRIOTT INTERNATIONAL INC /MD/
Option exercise
M$3.39M
8,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

30
SJ
Smith Fred Julius IIIDirector, President and CEO, Member of 10% Owner Group
ROADConstruction Partners, Inc.
Tax withholding
F$1.42M
14.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
SE
Skelly Noreen EDirector
ROADConstruction Partners, Inc.
Open-market purchase
BUY$7,970
100 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

29
CH
Ctt Pharmaceutical Holdings, Inc.Director, CEO
CTTHCtt Pharmaceutical Holdings, Inc.
Open-market purchase
BUY$450
9,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Open-market sale
SELL$134K
950 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
EK
Equels Thomas KDirector, CEO & President
AIMAIM ImmunoTech Inc.
Open-market purchase
BUY$3,167
20.3K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

29
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$35K
5,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

29
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$35K
5,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

29
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Tax withholding
F$20.86M
40.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
KP
Kiai ParsaDirector
MEDMEDIFAST INC
Open-market purchase
BUY$8,610
661 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Open-market sale
SELL$136K
950 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Open-market sale
SELL$138K
950 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$60K
120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

29
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Open-market sale
SELL$130K
950 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$33K
35 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
NW
Namkung James WChief Accounting Officer
ICEIntercontinental Exchange, Inc.
Open-market sale · 10b5-1 plan
SELL$661K
3,777 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
AM
Alvord Christina MDirector
APOGAPOGEE ENTERPRISES, INC.
Open-market purchase
BUY$2,416
52 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
PM
Patten Jarrod MDirector
MSTRStrategy Inc
Open-market sale
SELL$132K
950 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

29
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Other acquisition or disposition
J$8.13M
16.1K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

28
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Open-market sale
SELL$444K
890 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

28
FR
Foxx Anthony RDirector
NXPINXP Semiconductors N.V.
Open-market sale
SELL$105K
400 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

28
KD
Krulik DouglasCAO and Interim CFO
PETSPETMED EXPRESS INC
Tax withholding
F$8,602
3,246 sh
Sep 27, 2025Nov 6, 2026
traded Sep 27, 2025
+405dSEC Form 4

Evidence

28
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Open-market sale
SELL$530K
1,066 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

28
HA
Haller Julia ADirector
BMYBRISTOL MYERS SQUIBB CO
Open-market sale
SELL$241K
3,800 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
LA
Love Scott AEVP - Wealth Management
WSBCWESBANCO INC
Open-market sale
SELL$60K
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
LA
Love Scott AEVP - Wealth Management
WSBCWESBANCO INC
Open-market sale
SELL$60K
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
NS
Noor ShainChief Technology Officer
SVIASilvia, Inc.
Grant or award
A—
502.5K sh
May 19, 2026Nov 6, 2026
traded May 19, 2026
+171dSEC Form 4

Evidence

28
Saba Capital Management, L.P.10% Owner
MXFMEXICO EQUITY & INCOME FUND INC
Open-market purchase
BUY$500K
24.1K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
JH
Jamieson Lisa H.Director
FORForestar Group Inc.
Open-market sale
SELL$74K
3,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
TC
Tal CohenPres. Market Platforms
NDAQNASDAQ, INC.
Open-market sale
SELL$250K
2,286 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

28
CS
Chowbey SanjayDirector, President and CEO
KMTKENNAMETAL INC
Open-market purchase
BUY$165K
7,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

28
FL
Francis LauraDirector, Chief Executive Officer
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$1.90M
75.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

27
Lindner Carl H IiiDirector, Co-CEO
AFGAMERICAN FINANCIAL GROUP INC
Other acquisition or disposition
J—
8,385 sh
Sep 16, 2026Nov 6, 2026
traded Sep 16, 2026
+51dSEC Form 4

Evidence